| Proteon Therapeutics is a privately held biotechnology company developing novel, first-in-class pharmaceuticals to address the critical, rapidly expanding medical needs of patients with vascular diseases. The company is leveraging a unique understanding of vascular remodeling to develop a pipeline of proprietary therapeutics. Proteon Therapeutics' first drug candidate improves blood flow during vascular surgery procedures by providing rapid, permanent, and localized vasodilation.
|
